Deliver an Evidence-based Smoking Cessation Intervention for Smokers Attending A&E Departments in Hong Kong
Implementation of an Evidence-based Smoking Cessation Intervention Comprising Brief Advice Plus Active Referrals for Smokers Attending Emergency Departments in Hong Kong
1 other identifier
interventional
1,603
1 country
1
Brief Summary
This project aims to deliver an evidence-based smoking cessation intervention comprising the provision of brief cessation advice to smokers attending emergency departments and active referral to existing smoking cessation services. The objectives are as follows:
- 1.To promote this evidence-based project to emergency departments in various hospitals under the Hospital Authority
- 2.To construct a network with non-governmental organisations (NGOs) to provide smoking cessation services
- 3.To train healthcare professionals to use the AWARD model to deliver brief cessation advice to smokers
- 4.To deliver brief cessation advice via healthcare professionals and actively refer smokers to existing smoking cessation services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2019
CompletedFirst Posted
Study publicly available on registry
January 28, 2019
CompletedStudy Start
First participant enrolled
August 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedAugust 3, 2023
August 1, 2023
3.5 years
January 23, 2019
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically validated abstinence of smokers at the 6-month follow-up
The self-reported quitters at the 6-month follow-up will be invited to participate in a biochemical validation (measurement of exhaled \[CO\] and salivary cotinine level). The criteria for validated abstinence are an exhaled CO level of less than 4 ppm and a saliva cotinine level of less than 10 ng/ml.
at the 6-month follow-up
Secondary Outcomes (5)
Biochemically validated abstinence of smokers at the 12-month follow-up
at the 12-month follow-up
Self-reported 7-day point prevalence of abstinence at the 6-month follow-up
at the 6-month follow-up
Self-reported 7-day point prevalence of abstinence at the 12-month follow-up
at the 12-month follow-up
Self-reported reduction of ≥ 50% in cigarette consumption at the 6-month follow-up
at the 6-month follow-up
Self-reported reduction of ≥ 50% in cigarette consumption at the 12-month follow-up
at the 12-month follow-up
Other Outcomes (28)
Number of emergency departments participated at the end of recruitment
at 10 months
Knowledge of the risk of smoking in trained healthcare professionals before the training workshops
baseline
Knowledge of the risk of smoking in trained healthcare professionals at the end of the training workshops
up to 1 week
- +25 more other outcomes
Study Arms (1)
Smokers attending A&E
EXPERIMENTALReceive an evidence-based smoking cessation intervention comprising brief advice plus active referrals for smokers attending emergency departments in Hong Kong.
Interventions
The trained healthcare professionals will be encouraged to deliver brief smoking cessation advice based on the AWARD model to smokers who attend emergency departments and are triaged as semi-urgent or non-urgent. The trained healthcare professionals will ask the smokers their smoking history, then deliver the warning message to the smokers. If the smokers refuse to quit immediately, the trained healthcare professionals will advise them to reduce the number of cigarettes smoked per day, with the goal of complete cessation within 6 months. The healthcare professionals will then actively refer smokers to the chosen service provider within 1 week of recruitment. Smokers will receive proactive telephone calls from the service providers, receive a leaflet about the health-related hazards of smoking and benefits of quitting, and a pocket-sized information card containing brief information about the existing smoking cessation services in Hong Kong.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- The University of Hong Konglead
- Chinese University of Hong Kongcollaborator
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Related Publications (1)
Li HCW, Xia W, Li L, Chen H, Ho LLK, Cheung KY, Xiao S, Chan YC, Chung OKJ. Evidence-based brief cessation advice plus active referral for emergency department patients who smoke: a single-arm, real-world clinical trial. BMC Med. 2025 Nov 27;23(1):714. doi: 10.1186/s12916-025-04534-9.
PMID: 41310683DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ho Cheung William Li, PhD
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2019
First Posted
January 28, 2019
Study Start
August 13, 2019
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
August 3, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After the project is completed and the results of the project has been published.
- Access Criteria
- Request could be sent to Principal Investigator
The relevant anonymized patient level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.